Connor, Clark & Lunn Investment Management (CC&L)’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $28.5K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $339K | Buy |
|
|||||
|
2022
Q2 | $382K | Sell |
|
|||||
|
2022
Q1 | $1.16M | Sell |
|
|||||
|
2021
Q4 | $1.46M | Buy |
|
|||||
|
2021
Q3 | $898K | Buy |
|
|||||
|
2021
Q2 | $494K | Sell |
|
|||||
|
2021
Q1 | $875K | Sell |
|
|||||
|
2020
Q4 | $665K | Sell |
|
|||||
|
2020
Q3 | $819K | Sell |
|
|||||
|
2020
Q2 | $1.24M | Sell |
|
|||||
|
2020
Q1 | $874K | Sell |
|
|||||
|
2019
Q4 | $1.63M | Sell |
|
|||||
|
2019
Q3 | $627K | Buy |
|
|||||
|
2019
Q2 | $872K | Sell |
|
|||||
|
2019
Q1 | $1.14M | Buy |
|
|||||
|
2018
Q4 | $567K | Buy |
|
|||||
|
2018
Q3 | $842K | Buy |
|
|||||
|
2018
Q2 | $579K | Buy |
|